Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Pregabalin Oral Solution
- Product Name
- 普瑞巴林口服溶液
- Approval Number
- 国药准字H20253240
- Approval Date
- Jan 24, 2025
NMPA
Multiple Electrolytes Injection（Ⅱ）
- Product Name
- 复方电解质注射液(Ⅱ)
- Approval Number
- 国药准字H20253252
- Approval Date
- Jan 24, 2025
NMPA
Multiple Electrolytes Injection（Ⅱ）
- Product Name
- 复方电解质注射液(Ⅱ)
- Approval Number
- 国药准字H20253253
- Approval Date
- Jan 24, 2025
NMPA
Memantine Hydrochloride Oral Solution
- Product Name
- 盐酸美金刚口服溶液
- Approval Number
- 国药准字H20249071
- Approval Date
- Oct 16, 2024
NMPA
Tenofovir alafenamide Fumarate Tablets
- Product Name
- 富马酸丙酚替诺福韦片
- Approval Number
- 国药准字H20244016
- Approval Date
- Jun 11, 2024
NMPA
Hydrotalcite Chewable Tablets
- Product Name
- 铝碳酸镁咀嚼片
- Approval Number
- 国药准字H20234501
- Approval Date
- Nov 21, 2023
NMPA
Clinical Trials
No trials found
News
No news found